LatestScientists Overcome Key Barrier to Self-Amplifying mRNA Vaccines
Health

Opinion: AI is Eroding Safeguards Against Biological Weapons

Ashish K. Jha
Opinion: AI is Eroding Safeguards Against Biological Weapons
Summary

Experts warn that artificial intelligence is lowering the technical barriers that have historically prevented the creation of biological weapons, creating urgent biosecurity concerns. According to health policy analyst Ashish Jha, defensive measures against AI-generated bioweapons will require years to develop, yet the threat is accelerating. This development has significant implications for public health preparedness and pandemic prevention strategies globally. The convergence of AI capabilities with biological knowledge poses unprecedented challenges for healthcare systems and disease control agencies. Puerto Rico's health infrastructure must remain vigilant regarding emerging biosecurity threats and pandemic readiness.

Stat News

Originally published on

STAT News

By Ashish K. Jha

Read full article(opens in new tab)

Fetched: September 28, 2026 at 10:02 AM

More news you might be interested in

View all
Scientists Overcome Key Barrier to Self-Amplifying mRNA Vaccines
Health
CancerCOVID-19

Scientists Overcome Key Barrier to Self-Amplifying mRNA Vaccines

Researchers at Queen Mary University of London have achieved a significant breakthrough in vaccine technology by finding a way to bypass cellular defense mechanisms that previously limited self-amplifying mRNA vaccines. This advancement allows cells to produce substantially more of the target protein, potentially making vaccines more effective at lower doses. The findings, published in Nature Communications, could revolutionize vaccine development across multiple diseases including infectious diseases and cancer treatments. Self-amplifying mRNA vaccines represent a promising frontier in immunotherapy, and overcoming these cellular barriers may accelerate development of next-generation vaccines with improved efficacy and reduced manufacturing costs.

12 hours ago
Medical Xpress
Dominican Republic Strengthens Medical Education Through Intensive Scientific Congress Agenda
Health

Dominican Republic Strengthens Medical Education Through Intensive Scientific Congress Agenda

The Dominican Republic hosted multiple scientific congresses this weekend organized by medical societies and specialized entities, bringing together national and international healthcare professionals across various medical disciplines. These conferences focused on professional development, scientific exchange, and continuing medical education through presentations, debates, and collaborative discussions. The events provided physicians and specialists with opportunities to stay current with the latest clinical research, treatment advances, and evidence-based practices in their respective fields. This type of continuing education is essential for maintaining high standards of patient care and ensuring healthcare providers remain informed about new diagnostic and therapeutic developments. Such gatherings strengthen the professional network and promote knowledge sharing within the medical community.

12 hours ago
DiarioSalud.do
Opinion: Researchers Discover New Structure Hidden in the Heart
Health
Heart Disease

Opinion: Researchers Discover New Structure Hidden in the Heart

Researchers have identified a previously unknown structural feature within the heart, one of the most thoroughly studied organs in medical science. This remarkable discovery remained hidden despite centuries of intensive cardiac research and examination. The finding demonstrates that even in well-established medical fields, careful observation and close examination can reveal significant anatomical details. Understanding this new cardiac structure may have important implications for how physicians diagnose and treat heart conditions in the future.

12 hours ago
STAT News
GLP-1 Drugs Shift from Medical Treatment to Lifestyle Enhancement for Affluent Consumers
Health
DiabetesObesity

GLP-1 Drugs Shift from Medical Treatment to Lifestyle Enhancement for Affluent Consumers

Blockbuster GLP-1 medications, originally developed to treat diabetes and obesity, are increasingly being marketed as lifestyle drugs for weight management in people without medical conditions. This shift reflects a growing trend where pharmaceutical companies reposition these medications from treating patients with chronic diseases to targeting affluent consumers seeking cosmetic weight loss. The change raises questions about equitable access, medical necessity, and the commercialization of healthcare, as wealthy individuals gain easier access to these in-demand drugs while patients with diabetes and obesity face shortages and affordability challenges.

12 hours ago
STAT News